{{Rsnum
|rsid=238416
|Gene=ERCC2
|Chromosome=19
|position=45353791
|Orientation=minus
|GMAF=0.3278
|Gene_s=ERCC2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 8.8 | 52.2 | 38.9
| HCB | 24.1 | 49.6 | 26.3
| JPT | 23.0 | 54.9 | 22.1
| YRI | 0.0 | 5.4 | 94.6
| ASW | 0.0 | 17.5 | 82.5
| CHB | 24.1 | 49.6 | 26.3
| CHD | 27.5 | 51.4 | 21.1
| GIH | 13.9 | 50.5 | 35.6
| LWK | 0.0 | 6.4 | 93.6
| MEX | 15.5 | 53.4 | 31.0
| MKK | 3.2 | 26.3 | 70.5
| TSI | 10.8 | 38.2 | 51.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22608006
|Title=Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}